A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in norway

Cancer Research

Volumn 57, Issue 18, 1997, Pages 3989-3992

  Bjørge, Tone ^a,b   Hakulinen, Timo ^e   Engeland, Anders ^a   Jellum, Egil ^f   Koskela, Pentti ^d   Lehtinen, Matti ^d   Luostarinen, Tapio ^g   Paavonen, Jorma ^h   Sapp, Martin ⁱ   Schiller, John ^j   Thoresen, Steinar ^a   Wang, Zhaohui ^c   Youngman, Linda ^k   Dillner, Joakim ^c,d  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f Kreftforeningen   (Norway)

^g FINNISH CANCER REGISTRY   (Finland)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ JOHANNES GUTENBERG UNIVERSITY   (Germany)

^j NATIONAL CANCER INSTITUTE   (United States)

^k UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RISK; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN CELL; MALE; NORWAY; PAPILLOMA VIRUS; PRIORITY JOURNAL; SEROCONVERSION; VIRUS CAPSID; WART VIRUS;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; CARCINOMA, SQUAMOUS CELL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NORWAY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; TUMOR VIRUS INFECTIONS;

EID: 0030850474     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54: 594-606, 1993.
2. Pisani, P., Parkin, D. M., and Ferlay, J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int. J. Cancer, 55: 891-903, 1993.
3. Tomatis, L., Aitio, A., Day, N. E., Heseltine, E., Kaldor, J., Miller, A. B., Parkin, D. M., and Riboli, E. Cancer. Causes, Occurrence and Control, IARC Sci. Publ. No. 100. Lyon, France: IARC, 1990.
4. Engeland, A., Haldorsen, T., Tretli, S., Hakulinen, T., Hörte, L. G., Luostarinen, T., Magnus, K., Schou, G., Sigvaldason, H., Storm, H. H., Tulinius, H., and Vaittinen, P. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic cancer registries. APMIS Suppl., 38: 1-124, 1993.
5. Day, N. E., and Varghese, C. Oesophageal cancer. Cancer Surv., 19-20: 43-54, 1994.
6. Syrjänen, K. J. Histological changes identical to those of condylomatous lesions found in the esophageal squamous cell carcinomas. Arch. Geschwulstforsch., 52: 283-292, 1982.
7. Chang, F., Syrjänen, S., Wang, L., and Syrjänen, K. Infectious agents in the etiology of esophageal cancer. Gastroenterology, 103: 1336-1348, 1992.
8. Suzuk, L., Noffsinger, A. E., Hui, Y. Z., and Fenoglio Preiser, C. M. Detection of human papillomavirus in esophageal squamous cell carcinoma. Cancer (Phila.), 78: 704-710, 1996.
9. Togawa, K., Jaskiewicz, K., Takahashi, T., Meltzer, S. J., and Rustgi, A. K. Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology, 107: 128-136, 1994.
10. IARC. Human papillomaviruses. IARC monographs on the evaluation of carcinogenis risks to humans. IARC Sci. Publ., 64: 1-409, 1995.
11. Dillner, J. Serology of human papillomavirus. Cancer J., 8: 264-269, 1995.
12. Dillner, J., Knekt, P., Schiller, J. T., and Hakulinen, T. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. Br. Med. J., 311: 1346, 1995.
13. Han, C., Qiao, G., Hubbert, N. L., Li, L., Sun, C., Wang, Y., Yan, M., Xu, D., Li, Y., Lowy, D. R., and Schiller, J. T. Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China. J. Natl. Cancer Inst. (Bethesda), 88: 1467-1471, 1996.
14. Jellum, E., Andersen, A., Lund-Larsen, P., Theodorsen, L., and Ørjasæter, H. Experiences of the Janus Serum Bank in Norway. Environ. Health Perspect., 103 (Suppl. 3): 85-88, 1995.
15. Lund, E. Pilot study for the evaluation of completeness of reporting to the Cancer Registry. In: Cancer Registry of Norway (ed.), Incidence of Cancer in Norway 1978, pp. 11-15. Oslo: Cancer Registry of Norway, 1981.
16. Heino, P., Eklund, C., Fredriksson-Shanazarian, V., Goldman, S., Schiller, J. T., and Dillner, J. Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J. Natl. Cancer Inst. (Bethesda), 87: 437-440, 1995.
17. Andersson-Ellström, A., Dillner, J., Hagmar, B., Schiller, J., and Forssman, L. No serological evidence for non-sexual spread of HPV16. Lancet, 344: 1435, 1994.
18. Andersson-Ellström, A., Dillner, J., Hagmar, B., Schiller, J., Sapp, M., Forssman, L., and Milsom, J. Comparison of development of serum antibodies to HPV 16 and HPV 33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex. Transm. Dis., 23: 234-238, 1996.
19. Dillner, J., Wiklund, F., Lenner, P., Eklund, C., Fredriksson-Shanazarian, V., Schiller, J. T., Hibma, M., Hallmans, G., and Stendahl, U. Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. Int. J. Cancer, 60: 377-382, 1995.
20. Kirnbauer, R., Hubbert, N. L., Wheeler, C. M., Becker, T. M., Lowy, D. R., and Schiller, J. T. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. Natl. Cancer Inst. (Bethesda), 86: 494-499, 1994.
21. Dillner, I., Kallings, I., Brihmer, C., Sikström, B., Koskela, P., Lehtinen, M., Schiller, J. T., Sapp, M., and Mårdh, P. A. Seropositivities to human papillomavirus types 16, 18 and 33 capsids and to Chlamydia trachomatis are markers of sexual behaviour. J. Infect. Dis., 173: 1394-1398, 1996.
22. Chua, K. L., Wiklund, F., Lenner, P., Ingström, T., Hallmans, G., Sapp, M., Schiller, J., Bergman, F., Wadell, G., Hjerpe, A., and Dillner, J. A prospective cohort study on the risk to develop cervical intraepithelial neoplasia among healthy subjects with serum antibodies to HPV, in comparison with presence of HPV DNA in Papanicolaou smears. Int. J. Cancer, 68: 54-59, 1996.
23. Wang, S. P., and Grayston, J. T. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organism in a new microtiter indirect immunofluorescence test. Am. J. Ophthalmol., 70: 367-374, 1970.
24. Feyerabend, C., and Russell, M. A. A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J. Pharm. Pharmacol., 42: 450-452, 1990.
25. 125I radioimmunoassay for cotinine by selective removal of bridge antibodies. Clin. Chem., 31: 118-121, 1985.
26. Mehta, C. R., and Patel, N. R. Exact logistic regression: theory and examples. Stat. Med. 14: 2143-2160, 1995.
27. Bjørge, T., Hennig, E. M., Skare, G. B., Søreide, O., and Thoresen, S. Ø. Second primary cancers in patients with carcinoma in situ of the uterine cervix. The Norwegian experience 1970-1992. Int. J. Cancer, 62: 29-33, 1995.
28. zur Hausen, H. Viruses in human cancers. Science (Washington DC), 254: 1167-1173, 1991.
29. Campo, M. S. Papillomas and cancer in cattle. Cancer Surv., 6: 39-54, 1987.
30. Wideroff, L., Schiffman, M. H., Nonnenmacher, B., Hubbert, N., Kirnbauer, R., Greer, C. E., Lowy, D., Lorincz, A. T., Manos, M. M., Glass, A. G., Scott, D. R., Sherman, M. E., Kurman, R. J., Buckland, J., Tarone, R. E., and Schiller, J. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J. Infect. Dis., 172: 1425-1430, 1995.
31. Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., Stanton, C. K., and Manos, M. M. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. (Bethesda), 85: 958-964, 1993.